Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Mississippi Insight for Jan. 11, 2026 - 2Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there'
- 3'Crammed into a cell with vermin at New Year'
- 4Looking for under-the-radar adventures? Try Norway's Vesterålen
- 5Illegal entries into Germany halve over two years, border police say
- They want better health care — so they're turning to crypto startups
- Extraordinary Miracles: The Cherished Islands for a Tropical Get-away
- A Time of Careful Eating: Individual Tests in Nourishment
- 'Senseless violence' erupts at Christmas tree lighting; 4 injured
- Survey: Protected And Versatile Men's Razor
- First Greenland, now Iceland? Annexation joke by Trump ally gets frosty response in the Arctic nation.
- The Secret Side of Italy: 12 Underrated Destinations Locals Don’t Want Tourists to Find
- EU delegation urges China to tighten export controls
- The pinch at the pump continues on
